The most-requested ad I saw last week was Matt McCall's "FDA aproval imminent" pitch about a drug that could save millions of lives (and mint fortunes, of course) -- not much certainty in my coverage of that touted "Summit," but I can share my dive into the weeds with you, the Thinkolator results, and a couple investments related to the tease if you'll click here.
We also looked into a pitch from Profits Run that says a little $4 stock is "like buying Berkshire Hathaway in 1967" .... who wouldn't be tempted by that, right? You can see what the stock is and get my quick take on it in just a moment, all you need do is click here for the Thinkolator results.
We also enjoyed a visit from Doc Gumshoe this week... this time around he's exploring ketamine, which you might think of as either a menace or a miracle. Where does Michael come down on that? Details in his column here.
And we also got a lot of questions in recent weeks about Matt Badiali's "Infinite Oil Well" -- that's the ad with all the pyramids, if that helps spur your memory. Is there some "revolutionary new technology" that's going to "unlock a $70 trillion windfall" for this special company? I bet you know my answer already, but click here for the full story.
Finally, as is our wont, we closed out the week for our favorite folks with the Friday File... the email actually had a bad link in it when I sent it out the first time, so my apologies on that, but the Friday File is below with the latest installment of the Annual Review for our Real Money Portfolio holdings... just a click away...
